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The biological properties of fungal immunogens have historically utilized testing of
isolated molecules. Recent findings, however, indicate that fungal glycans differing in
structure and function can interact to form hybrid complexes with unique properties.
In the pathogenic yeast Cryptococcus neoformans, chitin-like molecules associate with
capsular glucuronoxylomannan (GXM) to form functionally distinct glycan complexes. Such
interactions between glycans that result in the formation of structures with different
functions strongly suggest that additional molecular complexes with unknown properties
may exist in fungal pathogens. Moreover, the identification of these novel complexes has
stimulated the search of new immunogens with potential to protect human and animal
hosts against systemic mycoses.
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The surface of fungal cells is rich in polysaccharides and protein-
or lipid-bound oligosaccharides (Nimrichter et al., 2005) that are
called glycans (Bertozzi and Rabuka, 2009). In the fungal cell
wall, polysaccharides, glycoproteins and glycolipids form com-
plex carbohydrate networks that play key physiological functions
(Nimrichter et al., 2005), such as providing structural support
and regulating extracellular secretion (Rodrigues et al., 2008b;
Casadevall et al., 2009). Notably, structural aspects of fungal gly-
cans differ considerably from those found in mammalian cells
(Fukazawa et al., 1995; Nimrichter et al., 2005). Therefore, the
uniqueness of wall glycans makes these molecules promising
targets for antimicrobial drugs, as extensively reviewed in the lit-
erature (Fukazawa et al., 1995; Nimrichter et al., 2005; Doering,
2009; Goldman and Vicencio, 2012).
Fungal glycans have diverse effects in the interplay between the
fungus and the host (Nimrichter et al., 2005). Carbohydrate-rich
molecules can effectively stimulate protective immune defenses
(Pirofski, 2001; Casadevall and Pirofski, 2006), but they can also
down-regulate host effector responses (Zaragoza et al., 2009).
To date, there has been an extraordinarily rich spectrum of fun-
gal glycans identified with activities ranging from activation of
innate responses and induction of humoral and cell-mediated
functions to inhibiting host effector cell recruitment and dysreg-
ulating cytokine responses (Casadevall and Pirofski, 2005, 2006;
Lee et al., 2008; Li et al., 2009; Sorgi et al., 2009; Mora-Montes
et al., 2011; Vecchiarelli et al., 2011). Examples of fungal glycans
showing contrasting biological activities are available in a num-
ber of comprehensive reviews and the impact of glycans from the
human pathogenic Cryptococcus neoformans have especially been
investigated (Fukazawa et al., 1995; San-Blas et al., 2000; Pirofski,
2001; Zaragoza et al., 2009; Vecchiarelli et al., 2011).
Experimental models describing structural and functional
aspects of fungal glycans have historically used purified
molecules, mutants lacking genes coding for glycan-synthesizing
enzymes, and specific glycan-binding probes, including antibod-
ies, lectins, and peptides. These classic approaches have tradition-
ally focused on isolatedmolecules for structural and/or functional
testing. Microscopic techniques, however, have clearly revealed
a number of molecular associations at the cell surface of fungi
(Maxson et al., 2007a,b; Rodrigues et al., 2008a; De Jesus et al.,
2009; Fonseca et al., 2009b; Zaragoza et al., 2009; Jesus et al.,
2010), which suggests that the study of isolated molecules is insuf-
ficient to fully elucidate the functional impact of these complex
structures. Inter and intramolecular non-covalent associations
keep cell wall structures compacted and prevent extracellular
release. These molecular complexes differ in structure and com-
position from isolated molecules, implying that functional differ-
ences may occur. To illustrate this hypothesis, we will focus on
C. neoformans, in which glycan complexes with unique functions
have been recently described.
The surface of C. neoformans is mainly composed of glycans
that include complex polysaccharides, protein-bound oligoman-
nosides, N-acetyl-glucosamine-rich oligosaccharides and gluco-
sylceramides (Rodrigues et al., 2000; Reese and Doering, 2003;
Nimrichter et al., 2005; Reese et al., 2007; Zaragoza et al., 2009;
Nimrichter and Rodrigues, 2011). The most striking feature of
C. neoformans is an external glycan capsule, which plays a number
of significant functions during infection and is crucial for dis-
ease progress (Zaragoza et al., 2009). Classically, the capsule has
been defined as a complex surface network composed of manno-
proteins and the heteropolysaccharides glucuronoxylomannan
(GXM) and glucuronoxylomannogalactan (GXMGal). GXM, the
main component of the capsule, is a potent immune modu-
lator that has been suggested as a vaccine candidate (Pirofski,
2001). Interestingly, a monoclonal antibody targeting GXM
(Casadevall et al., 1998) has undergone phase I clinical testing
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for use in the treatment of cryptococcosis (Larsen et al., 2005).
GXMGal, a minor capsular component, can induce apoptosis
in immune cells (Villena et al., 2008). Cryptococcal manno-
proteins are efficient stimulators of T cell-mediated immune
responses (Levitz and Specht, 2006). These molecules are sta-
bly connected to the cell wall and require γ-radiation or DMSO
treatment to be detached from the fungal surface (Maxson et al.,
2007a,b).
During the last five years, a number of studies have demon-
strated that the complexity of the C. neoformans capsule is greater
than previously thought (Rodrigues et al., 2009). For instance,
GXM can self-aggregate (Nimrichter et al., 2007), producing
polysaccharide samples that differ in both biophysical and sero-
logical properties from fractions obtained through classical bio-
chemical methods (Frases et al., 2008). In addition, microscopic
analyses in combination with gene deletion and biochemical
approaches strongly suggest that, within the capsular microen-
vironment, GXM interacts with other glycans, including α1,3
glucan (Reese and Doering, 2003; Reese et al., 2007), GXMGal
(De Jesus et al., 2009), mannoproteins (Jesus et al., 2010), and
chitin-like structures (Rodrigues et al., 2008a). These studies have
led investigators to question the prior models of the structure
of the C. neoformans capsule, and have led us and others to ask
whether the association of GXM with other glycans produces
functionally different molecules. This question has been initially
addressed in an experimental model testing the association of
GXM with chitin-like structures (Ramos et al., 2012), as detailed
below.
Chitin is composed of β1,4 linked units of N-acetyl-
glucosamine. This water-insoluble polysaccharide is a scaffold
component of the fungal cell wall (Nimrichter et al., 2005), that is
not normally accessible to the immune system. During cell divi-
sion, chitin is hydrolyzed through the activity of chitinases, result-
ing in the formation of chitooligomers (Kuranda and Robbins,
1991; Adams, 2004). In Saccharomyces cerevisiae, these molecules
accumulate in bud scars (Powell et al., 2003). However, the dis-
tribution of cell wall chitooligomers in C. neoformans seems to
be unique, as these molecules are intercalated within the capsular
network (Figure 1) (Rodrigues et al., 2008a). The wide distribu-
tion of GXM in the capsule, in fact, supports the hypothesis that
this polysaccharide has the potential to interact with peripheral
components, including chitin oligosaccharides.
The supposition that GXM and chitin-derived structures inter-
act has been confirmed by a number of approaches (Rodrigues
et al., 2008a; Fonseca et al., 2009a,b; Ramos et al., 2012).
Using chromatographic and serologic methods in combina-
tion with dynamic light scattering, GXM has been shown to
interact with chitin and chitooligomers based on the facts
that: (1) complexes containing both structures have been iso-
lated from C. neoformans cultures, (2) chitooligomers promoted
enlargement of GXM fibrils, and (3) exposure of C. neofor-
mans cells to an inhibitor of N-acetylglucosamine synthesis
caused a decrease in capsular dimensions (Fonseca et al., 2009b).
Although these studies were in agreement with the ability of
C. neoformans to form glycan complexes composed of chitin-
derived structures and GXM, their production during infection,
impact on the host’s immune system, and structural determinants
FIGURE 1 | Confocal section of budding C. neoformans cells. Cell wall
chitin (blue fluorescence), capsular GXM (green fluorescence) and chitin
oligosaccharides at the cell wall-capsule interface (red fluorescence) were
stained as described in Rodrigues et al. (2008a). The image demonstrates
that chitin oligosaccharides interact with GXM. Scale bar, 1μm.
regulating this glycan-glycan interaction were unknown until very
recently.
A recent study (Ramos et al., 2012) has demonstrated that
chitin-GXM association involves non-covalent bonds, large GXM
fibers, and depends on the N-acetyl amino group of chitin,
but not on carboxyl and O-acetyl groups of GXM. Importantly,
this study shows that glycan complexes formed by GXM and
chitin-derived molecules also arise during macrophage infection.
Injection of either isolated molecules or the glycan complexes
into mice induced distinctly different cytokine responses. In
fact, the glycan complexes were efficient in inducing the pro-
duction of lung IL-10, IL-17, and TNFα, while the cytokine
profiles of mice challenged with either GXM or chitin oligomers
alone were similar to cytokine levels in control animals. The fact
that glycan complex structures produce enhanced immunosup-
pressive and pro-inflammatory cytokine responses while chitin
oligomers and GXM alone did not suggested that cell-associated
C. neoformans glycans form hybrid structures with unique
functions.
The discovery of the formation of functionally distinct glycan
complexes raises a number of puzzling questions. For instance,
the surface of fungal pathogens is decorated with many different
glycans that coexist in several microenvironments (Nimrichter
et al., 2005). In fact, many of these molecules are also released
into the extracellular space (Rodrigues and Djordjevic, 2012).
Therefore, isolated and complexed molecules may interact simul-
taneously but discordantly with the immune system. Considering
the differential response of lung cells to isolated and hybrid
molecules in the C. neoformans model (Ramos et al., 2012), it is
reasonable to postulate that different receptors may be involved
in the immune response to each molecular species. The physi-
ologic events regulating the formation of the components of the
glycan complex have largely been elusive. For instance, hybrid gly-
can complexes composed of chitin oligosaccharides and GXM are
found in the capsule (Fonseca et al., 2009b) and in the extra-
cellular space (Ramos et al., 2012), implying the requirement
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of secretory mechanisms for transporting these macromolecules
across the fungal cell wall. In fact, GXM is secreted to the cell
surface and to the extracellular space by vesicular mechanisms
(Yoneda and Doering, 2006; Rodrigues et al., 2007), but secretory
processes resulting in the export of chitin oligosaccharides are
not known. In this context, it has been established by a number
of studies that polymerization and hydrolysis of fungal polysac-
charides are surface-associated events (Adams, 2004), with GXM
being the only well-known exception (Yoneda and Doering, 2006;
Rodrigues et al., 2011). Consequently, it would be reasonable to
suppose that the generation of soluble oligosaccharides partic-
ipating in glycan interactions depends on hydrolytic enzymatic
activity.
Chitooligomers are the products of enzymatic hydrolysis of
chitin. Chitinase expression is induced during pulmonary crypto-
coccosis in rodents (Vicencio et al., 2008) and in the bronchoalve-
olar lavage fluid of asthmatic children (Goldman et al., 2012).
The surface distribution of chitooligomers in C. neoformans is
in fact increased in the lungs of infected rats (Fonseca et al.,
2009b). It is also likely that chitooligomers produced through the
activity of chitinase are released to the extracellular space, consid-
ering their high hydrophilicity and consequent solubility in water.
GXM, on the other hand, is constitutively secreted extracellularly
(Zaragoza et al., 2009). The concentration of hybrid glycans is
severely reduced in cultures with methylxanthine, an inhibitor of
fungal chitinases (Ramos et al., 2012). The reduced formation of
hybrid glycan complexes as a consequence of chitinase inhibition
is in accord with in vivo observations demonstrating that chi-
tooligomer detection and capsule enlargement are more evident
in host tissues manifesting higher activity of this enzyme (Fonseca
et al., 2009b). Therefore, a putative synergistic or additive activity
of host and fungal chitinases cannot be discarded.
GXM has the potential to associate with a number of
hydrophilic components, mainly because of its high efficiency in
the formation of hydrogen bonds. Thus, GXM-chitin interactions
probably have other counterparts in C. neoformans. Microscopic
examinations of C. neoformans yeast cells, in fact, support this
possibility. Co-staining of cryptococci with antibodies raised to
GXM and to α1,3 glucan reveal that α1,3 glucan is widely dis-
tributed in the capsule (Cordero et al., 2011). Nevertheless, α1,3
glucan is well known as a cell wall polysaccharide responsible
for anchoring C. neoformans GXM (Reese and Doering, 2003;
Reese et al., 2007), and has not previously been considered as a
capsular component. Such unexpected cellular distribution may
be linked to enzyme-dependent generation of α1,3 glucan frag-
ments. Glucans are dynamically polymerized and hydrolyzed
during cell wall remodeling and yeast replication (Adams, 2004),
resulting in the production of soluble glucan oligosaccharides as
a natural consequence of cell division. In C. neoformans, the pres-
ence of the capsule is well-known to slow down the molecular
traffic across the cell surface (Nosanchuk et al., 1998; Rodrigues
et al., 2000), supporting the possibility that glucan-derived
oligosaccharides could be retained within the capsular network
after enzymatic hydrolysis. Such mechanism would result in the
formation of hybrid microenvironments composed of GXM and
glucan-derived oligosaccharides that are compatible with the flu-
orescence profile observed by Cordero and colleagues (2011)
FIGURE 2 | Fluorescence microscopy of C. neoformans after staining
for cell wall chitin (blue fluorescence), capsular GXM (green
fluorescence) and α1,3 glucan (red fluorescence). The capsular
distribution of α1,3 glucan suggests that the glycan is interacting with GXM
and supports the hypothesis that the fungus forms hybrid polysaccharides.
For experimental details, see Cordero et al. (2011). Image provided by
Dr. Radames, J. B. Cordero. Scale bar, 1μm.
and illustrated in Figure 2. Structural determinations regulating
GXM-glucan interactions are still unknown, although hydrogen
bonds are likely involved in polysaccharide-polysaccharide inter-
actions (Fonseca et al., 2009b; Ramos et al., 2012). Importantly,
these molecules have the potential to form unique glycan com-
plexes, as observed for GXM-chitin oligosaccharides. Such ratio-
nale could be also be applicable to other cell wall and capsular
components, including β-glucans, GXMGal and mannoproteins.
Surface molecules do not exist in their isolated form in cellular
systems and approaches investigating interacting molecules can
provide a deeper understanding of complex biological processes
than the study of individual purified molecules. The discovery of
hybrid glycans with previously unknown functions suggests new
venues of investigation on the roles of polysaccharides and gly-
coconjugates in fungal infections. In addition, the connections
between glycan association and functional variation strongly
indicate that molecular complexes with still unknown proper-
ties may exist in fungal pathogens. This conclusion encourages
new perspectives on models aiming at the discovery of protective
immunogens.
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